Pharmaceutical giant Pfizer Inc. on Wednesday raised its fiscal 2015 outlook for adjusted earnings as well as revenue, but lowered its guidance for full-year reported earnings. The revised financial outlook for the year is solely to reflect the impact of Pfizer’s recently completed $15.2 billion acquisition of hospital products maker Hospira Inc.